ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

Two Workshops To Look For New Research Areas

October 29, 1976

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

Three Nutrition RFPs withdrawn Due To “Vagueness”

July 8, 1977

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011